Abstract

BackgroundWe have developed a gene expression assay (Whole-Genome DASL®), capable of generating whole-genome gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens.Methodology/Principal FindingsWe demonstrated a similar level of sensitivity in gene detection between matched fresh-frozen (FF) and FFPE samples, with the number and overlap of probes detected in the FFPE samples being approximately 88% and 95% of that in the corresponding FF samples, respectively; 74% of the differentially expressed probes overlapped between the FF and FFPE pairs. The WG-DASL assay is also able to detect 1.3–1.5 and 1.5–2 -fold changes in intact and FFPE samples, respectively. The dynamic range for the assay is ∼3 logs. Comparing the WG-DASL assay with an in vitro transcription-based labeling method yielded fold-change correlations of R2 ∼0.83, while fold-change comparisons with quantitative RT-PCR assays yielded R2∼0.86 and R2∼0.55 for intact and FFPE samples, respectively. Additionally, the WG-DASL assay yielded high self-correlations (R2>0.98) with low intact RNA inputs ranging from 1 ng to 100 ng; reproducible expression profiles were also obtained with 250 pg total RNA (R2∼0.92), with ∼71% of the probes detected in 100 ng total RNA also detected at the 250 pg level. When FFPE samples were assayed, 1 ng total RNA yielded self-correlations of R2∼0.80, while still maintaining a correlation of R2∼0.75 with standard FFPE inputs (200 ng).Conclusions/SignificanceTaken together, these results show that WG-DASL assay provides a reliable platform for genome-wide expression profiling in archived materials. It also possesses utility within clinical settings where only limited quantities of samples may be available (e.g. microdissected material) or when minimally invasive procedures are performed (e.g. biopsied specimens).

Highlights

  • Formalin-fixed, paraffin-embedded (FFPE) tissues represent an invaluable resource for cancer research, as they are the most widely available material for which patient outcomes are known

  • To overcome the technical limitations to microarray-based analyses of FFPE samples, we previously developed a sensitive and reproducible gene expression profiling assay, DASL, for parallel analysis of hundreds of genes with highly degraded RNA samples [9,10,11]

  • Assay Reproducibility To assess the reproducibility of the WG-DASL assay we initially used inputs of 200 ng total RNA extracted from six different ovarian tumor FFPE tissues

Read more

Summary

Introduction

Formalin-fixed, paraffin-embedded (FFPE) tissues represent an invaluable resource for cancer research, as they are the most widely available material for which patient outcomes are known. While most other technologies rely on multiple rounds of random priming for sample amplification and labeling [3], DASL only generates first strand cDNA that minimizes variation that arises during the random priming This technology has been successfully used to profile a variety of archived FFPE tumor samples, some of which have been in storage for as long as 24 years [12] and for which, in many cases, little or no tissue handling and fixation details are known, including colon [10,11], breast [10,11,13,14,15,16], lung [11,14], prostate [11,12,17,18,19], bladder [16], and liver [20] cancer. We have developed a gene expression assay (Whole-Genome DASLH), capable of generating whole-genome gene expression profiles from degraded samples such as formalin-fixed, paraffin-embedded (FFPE) specimens

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call